Skip to content

In the BioHarmony Drug Report Database

Rasburicase

Elitek, Fasturtec (rasburicase) is an enzyme pharmaceutical. Rasburicase was first approved as Elitek on 2001-02-23. It is used to treat hyperuricemia and tumor lysis syndrome in the USA. It has been approved in Europe to treat hyperuricemia.
Trade Name Fasturtec
Common Name Rasburicase
Indication hyperuricemia, tumor lysis syndrome
Drug Class Enzymes
Rasburicase
Get full access now